"
Template:SupbiotechparisEn
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 78: | Line 78: | ||
| - | <div id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;"> | + | <div id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Ethics & Safety</div> |
[[Team:SupBiotech-Paris/Ethic#drapeau|Ethics]] | [[Team:SupBiotech-Paris/Ethic#drapeau|Ethics]] | ||
[[Team:SupBiotech-Paris/Safety#drapeau|Safety]] | [[Team:SupBiotech-Paris/Safety#drapeau|Safety]] | ||
Revision as of 23:39, 21 October 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
